メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
1 Insulin Delivery Systems Market Overview
1.1 Insulin Delivery Systems Product Overview
1.2 Insulin Delivery Systems Market Segment by Type
1.2.1 Pens
1.2.2 Pumps
1.2.3 Pen Needles
1.2.4 Syringes
1.3 Global Insulin Delivery Systems Market Size by Type
1.3.1 Global Insulin Delivery Systems Sales and Growth by Type
1.3.2 Global Insulin Delivery Systems Sales and Market Share by Type (2015-2020)
1.3.3 Global Insulin Delivery Systems Revenue and Market Share by Type (2015-2020)
1.3.4 Global Insulin Delivery Systems Price by Type (2015-2020)
2 Global Insulin Delivery Systems Market Competition by Company
2.1 Global Insulin Delivery Systems Sales and Market Share by Company (2015-2020)
2.2 Global Insulin Delivery Systems Revenue and Share by Company (2015-2020)
2.3 Global Insulin Delivery Systems Price by Company (2015-2020)
2.4 Global Top Players Insulin Delivery Systems Manufacturing Base Distribution, Sales Area, Product Types
2.5 Insulin Delivery Systems Market Competitive Situation and Trends
2.5.1 Insulin Delivery Systems Market Concentration Rate
2.5.2 Global Insulin Delivery Systems Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Insulin Delivery Systems Company Profiles and Sales Data
3.1 Becton, Dickinson and Company
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Insulin Delivery Systems Product Category, Application and Specification
3.1.3 Becton, Dickinson and Company Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.1.4 Main Business Overview
3.2 Novo Nordisk
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Insulin Delivery Systems Product Category, Application and Specification
3.2.3 Novo Nordisk Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.2.4 Main Business Overview
3.3 Medtronic
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Insulin Delivery Systems Product Category, Application and Specification
3.3.3 Medtronic Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.3.4 Main Business Overview
3.4 Sanofi
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Insulin Delivery Systems Product Category, Application and Specification
3.4.3 Sanofi Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.4.4 Main Business Overview
3.5 ELI Lilly and Company
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Insulin Delivery Systems Product Category, Application and Specification
3.5.3 ELI Lilly and Company Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.5.4 Main Business Overview
3.6 Ypsomed Holding
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Insulin Delivery Systems Product Category, Application and Specification
3.6.3 Ypsomed Holding Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.6.4 Main Business Overview
3.7 Animas Corporation
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Insulin Delivery Systems Product Category, Application and Specification
3.7.3 Animas Corporation Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.7.4 Main Business Overview
3.8 Tandem Diabetes Care
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Insulin Delivery Systems Product Category, Application and Specification
3.8.3 Tandem Diabetes Care Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.8.4 Main Business Overview
3.9 Insulet Corporation
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Insulin Delivery Systems Product Category, Application and Specification
3.9.3 Insulet Corporation Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.9.4 Main Business Overview
3.10 Biocon
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Insulin Delivery Systems Product Category, Application and Specification
3.10.3 Biocon Insulin Delivery Systems Sales, Revenue, Price and Gross Margin(2015-2020)
3.10.4 Main Business Overview
4 Insulin Delivery Systems Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Insulin Delivery Systems Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Insulin Delivery Systems Sales and Revenue by Regions
4.2.1 Global Insulin Delivery Systems Sales and Market Share by Regions (2015-2020)
4.2.2 Global Insulin Delivery Systems Revenue and Market Share by Regions (2015-2020)
4.2.3 Global Insulin Delivery Systems Sales, Revenue, Price and Gross Margin (2015-2020)
4.3 North America Insulin Delivery Systems Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Insulin Delivery Systems Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Insulin Delivery Systems Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Insulin Delivery Systems Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Insulin Delivery Systems Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Insulin Delivery Systems Application/End Users
5.1 Insulin Delivery Systems Segment by Application
5.1.1 Patients/Homecare
5.1.2 Hospitals & Clinics
5.2 Global Insulin Delivery Systems Product Segment by Application
5.2.1 Global Insulin Delivery Systems Sales by Application
5.2.2 Global Insulin Delivery Systems Sales and Market Share by Application (2015-2020)
6 Global Insulin Delivery Systems Market Forecast
6.1 Global Insulin Delivery Systems Sales, Revenue Forecast (2021-2028)
6.1.1 Global Insulin Delivery Systems Sales and Growth Rate Forecast (2021-2028)
6.1.1 Global Insulin Delivery Systems Revenue and Growth Rate Forecast (2021-2028)
6.2 Global Insulin Delivery Systems Forecast by Regions
6.2.1 North America Insulin Delivery Systems Sales and Revenue Forecast (2021-2028)
6.2.2 Europe Insulin Delivery Systems Sales and Revenue Forecast (2021-2028)
6.2.3 Asia-Pacific Insulin Delivery Systems Sales and Revenue Forecast (2021-2028)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Insulin Delivery Systems Sales and Revenue Forecast (2021-2028)
6.2.5 Middle East and Africa Insulin Delivery Systems Sales and Revenue Forecast (2021-2028)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Insulin Delivery Systems Forecast by Type
6.3.1 Global Insulin Delivery Systems Sales and Revenue Forecast by Type (2021-2028)
6.3.2 Pens Gowth Forecast
6.3.3 Pumps Gowth Forecast
6.4 Insulin Delivery Systems Forecast by Application
6.4.1 Global Insulin Delivery Systems Sales Forecast by Application (2021-2028)
6.4.2 Global Insulin Delivery Systems Forecast in Patients/Homecare
6.4.3 Global Insulin Delivery Systems Forecast in Hospitals & Clinics
7 Insulin Delivery Systems Upstream Raw Materials
7.1 Insulin Delivery Systems Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Insulin Delivery Systems Industrial Chain Analysis
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
